CPL @1111 (87.7%) on 25-jun-2018 [ "dose of _" "hypersensitivity reactions to _" "serious side effects , stop taking _" "antibiotics , including _" "liquid form of _" "normal dose of _" "antibiotics such as _" "DD-day course of _" "patients treated with _" "pharmacokinetics of _" "single dose of _" "cross-resistance between _" "children treated with _" "overdose of _" "doses of _" "Prolonged use of _" "side effects from _" "cross-reactivity between _" "known hypersensitivity to _" "_ was the only drug" "treatment with _" "clinical trials with _" "antibacterial agents , including _" "allergic reaction to _" "effects , stop taking _" "side effects of _" "patients receiving _" "dosage of _" "therapy with _" "possible side effects of _" "infections caused by _" "you are taking _" "you are allergic to _" "patients being treated with _" "side effects , stop taking _" "medications such as _" "oral therapy with _" "cephalosporins such as _" "medicines like _" "prescribing of _" "MIC for _" "antibiotics , such as _" ] using cefaclor
relations
NELL has only weak evidence for items listed in grey